StockNews.com upgraded shares of CVS Health (NYSE:CVS - Free Report) from a sell rating to a hold rating in a research report report published on Thursday.
Several other equities research analysts have also issued reports on CVS. Cantor Fitzgerald upgraded CVS Health from a "neutral" rating to an "overweight" rating in a report on Wednesday. Mizuho reduced their target price on CVS Health from $73.00 to $66.00 and set an "outperform" rating for the company in a report on Thursday, October 24th. Royal Bank of Canada reduced their target price on CVS Health from $68.00 to $58.00 and set an "outperform" rating for the company in a report on Friday, November 15th. Deutsche Bank Aktiengesellschaft upgraded CVS Health from a "hold" rating to a "buy" rating and set a $66.00 target price for the company in a report on Tuesday, December 3rd. Finally, Barclays boosted their target price on shares of CVS Health from $71.00 to $73.00 and gave the stock an "overweight" rating in a research report on Thursday. Four equities research analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $70.28.
Get Our Latest Stock Analysis on CVS Health
CVS Health Stock Down 1.0 %
Shares of CVS stock traded down $0.67 during trading on Thursday, hitting $65.71. 10,208,186 shares of the company were exchanged, compared to its average volume of 12,149,901. The firm has a market capitalization of $82.68 billion, a price-to-earnings ratio of 16.68, a P/E/G ratio of 0.60 and a beta of 0.61. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The business's 50-day simple moving average is $51.11 and its 200 day simple moving average is $56.04. CVS Health has a twelve month low of $43.56 and a twelve month high of $80.75.
CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings results on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, beating the consensus estimate of $0.89 by $0.30. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. As a group, analysts forecast that CVS Health will post 5.14 EPS for the current fiscal year.
CVS Health Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd were issued a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 4.05%. The ex-dividend date was Thursday, January 23rd. CVS Health's payout ratio is currently 67.51%.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently modified their holdings of the business. Coppell Advisory Solutions LLC boosted its holdings in shares of CVS Health by 17.3% in the 4th quarter. Coppell Advisory Solutions LLC now owns 1,282 shares of the pharmacy operator's stock worth $56,000 after acquiring an additional 189 shares in the last quarter. Integrated Advisors Network LLC lifted its position in CVS Health by 0.7% during the 3rd quarter. Integrated Advisors Network LLC now owns 27,625 shares of the pharmacy operator's stock worth $1,737,000 after buying an additional 200 shares in the last quarter. Widmann Financial Services Inc. lifted its position in CVS Health by 1.8% during the 3rd quarter. Widmann Financial Services Inc. now owns 11,506 shares of the pharmacy operator's stock worth $724,000 after buying an additional 200 shares in the last quarter. EagleClaw Capital Managment LLC lifted its position in CVS Health by 3.4% during the 4th quarter. EagleClaw Capital Managment LLC now owns 6,135 shares of the pharmacy operator's stock worth $275,000 after buying an additional 200 shares in the last quarter. Finally, DT Investment Partners LLC lifted its position in CVS Health by 7.8% during the 3rd quarter. DT Investment Partners LLC now owns 2,777 shares of the pharmacy operator's stock worth $175,000 after buying an additional 202 shares in the last quarter. 80.66% of the stock is owned by institutional investors and hedge funds.
CVS Health Company Profile
(
Get Free Report)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
Featured Articles
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
